Bio-Techne (TECH) Accounts Payables (2010 - 2026)
Bio-Techne (TECH) posted quarterly Accounts Payables of $23.5 million for Q1 2026, down 25.77% year-over-year from $31.6 million in Q1 2025, and down 10.58% quarter-over-quarter from $26.3 million in Q4 2025.
Bio-Techne (TECH) Accounts Payables (2010 - 2026) Analysis & Trends
Bio-Techne's Accounts Payables history runs 17 years deep, the most recent figure standing at $23.5 million for Q1 2026.
- In Q1 2026, Accounts Payables fell 25.77% year-over-year to $23.5 million; the TTM figure through Mar 2026 stood at $23.5 million (down 25.77% YoY), while the FY2025 annual figure was $25.3 million, down 33.34% from the prior year.
- Accounts Payables for Q1 2026 stood at $23.5 million, down from $26.3 million in the prior quarter.
- The five-year high for Accounts Payables was $38.0 million in Q2 2024, with the low at $23.5 million in Q1 2026.
- The 5-year median for Accounts Payables is $30.2 million (2025), against an average of $29.4 million.
- The sharpest annual moves came in 2024 and 2025: Accounts Payables jumped 47.86% in 2024, then sank 33.34% in 2025.
- Bio-Techne's Accounts Payables stood at $24.1 million in 2022, then jumped by 30.76% to $31.5 million in 2023, then gained by 5.1% to $33.1 million in 2024, then dropped by 20.69% to $26.3 million in 2025, then decreased by 10.58% to $23.5 million in 2026.
- Business Quant data shows TECH's Accounts Payables at $23.5 million in Q1 2026, $26.3 million in Q4 2025, and $30.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Bio-Techne | 11.33 Bn | 11.12 Bn | 208.29 Mn | 23.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.49 Mn |
| Dec 31, 2025 | 26.27 Mn |
| Sep 30, 2025 | 30.16 Mn |
| Jun 30, 2025 | 25.31 Mn |
| Mar 31, 2025 | 31.64 Mn |
| Dec 31, 2024 | 33.12 Mn |
| Sep 30, 2024 | 31.56 Mn |
| Jun 30, 2024 | 37.97 Mn |
| Mar 31, 2024 | 28.90 Mn |
| Dec 31, 2023 | 31.51 Mn |
| Sep 30, 2023 | 28.08 Mn |
| Jun 30, 2023 | 25.68 Mn |
| Mar 31, 2023 | 27.12 Mn |
| Dec 31, 2022 | 24.10 Mn |
| Sep 30, 2022 | 30.48 Mn |
| Jun 30, 2022 | 33.87 Mn |
| Mar 31, 2022 | 30.86 Mn |
| Dec 31, 2021 | 26.76 Mn |
| Sep 30, 2021 | 25.62 Mn |
| Jun 30, 2021 | 29.38 Mn |